(Q46987627)
Statements
Superiority of prolonged low-dose azanucleoside administration? Results of 5-aza-2'-deoxycytidine retreatment in high-risk myelodysplasia patients (English)
Björn Rüter
Pierre W Wijermans
Michael Lübbert
1 April 2006
106
8
1744-1750
1 reference